Potential Drugs and Chemotherapeutants for Marine Shrimp Production: Selection, Evaluation, and Approval Processes, Year 03
July 1, 1989
|Hawaii||$193,000||University of Arizona, University of Hawaii at Manoa, and Hawaii Aquaculture Development Program||D.V. Lightner and T.A. Bell|
- Define significant disease problems of penaeid shrimp rearing facilities and in particular those diseases that appear to be potentially treatable.
- Identify and test likely drugs and/or chemotherapeutants for the treatment of disorders or syndromes, previously defined (in #1 above) as potentially treatable. Additional criteria for the selection of candidate compounds will be: reported efficacy, industry sponsor interest, and potential for government approval under current Federal regulations.
- In cooperation with an industry sponsor(s), obtain approval for the selected compound(s) from the appropriate Federal government agency.
- Perform studies that will identify and lead to the approval of one or more orally administered (via bioencapsulated and prepared feeds) antibacterial therapeutants.